Exam Proctoring Softwares Draw Criticisms Over Student Privacy

There’s no question that the remote learning technology that popped up and evolved during the COVID-19 pandemic helped students and teachers engage from a distance under truly extraordinary circumstances.

However, now that the dust has settled, concerns have arisen – specifically around the privacy rights of students asked to take exams and complete other work under the watchful eye of online proctoring services like ProctorU.

Online exam proctoring methods have been drawing heavy criticism due to their often vague set of policies and best practices, as well extremely present and invasive forms of monitoring.

These services often use technologies like facial recognition, mouse movement control and system performance control, raising pertinent questions about how far is too far in the quest to ensure a level playing field.

Another online proctor, Examus, claims it uses eye-tracking, technology that scans student environments for other people in the room, and what it calls “emotion detection.”

On this MarketScale Industry Update, Kevin Hogan, host of MarketScale’s Remote Possibilities, joined host Daniel Litwin to discuss the factors that make students feel the need to cheat, and explore how school districts can better account for privacy moving forward, which technologies are truly necessary, strategies that enhance remote and hybrid learning without being overly focused on punitive measures, and more.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More